ARVINAS, INC. (ARVN)

↓ Download CSV

CIK 0001655759 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ARVINAS, INC. reported revenue of $262.60M, down 0.3% from the prior year. The company ran a net loss, with a net margin of -30.8%. It held $717.90M in total assets against $284.00M in total liabilities.

Key ratios (FY2025)

-45.1%
Operating margin
-30.8%
Net margin
-18.6%
Return on equity
-0.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$262.60M$263.40M$78.50M$131.40M$53.60M$25.90M$43.00M$14.32M$7.58M
Operating Income-$118.50M-$250.20M-$401.50M-$263.20M-$188.40M-$120.80M-$51.50M-$43.80M-$24.76M
Net Income-$80.80M-$198.90M-$367.30M-$282.50M-$191.00M-$119.30M-$70.30M-$41.48M-$24.05M
EPS (Diluted)$-1.14$-2.77$-6.62$-5.31$-3.82$-3.02$-2.13
Total Assets$717.90M$1.09B$1.30B$1.27B$1.58B$717.40M$301.64M$199.28M$66.85M
Total Liabilities$284.00M$529.70M$644.60M$703.90M$799.90M$75.20M$74.96M$62.61M$66.60M
Shareholders' Equity$433.90M$561.70M$660.00M$564.90M$781.70M$642.20M$226.60M$136.60M-$61.23M-$32.88M
Cash & Equivalents$142.90M$100.50M$311.70M$81.30M$108.30M$588.40M$9.21M$3.19M$30.91M
Operating Cash Flow-$273.80M-$259.30M-$347.80M-$273.50M$559.40M-$89.70M-$40.60M-$16.12M$5.11M
Capital Expenditures$1.90M$1.80M$2.90M$6.80M$4.70M$6.40M$6.30M$2.83M$1.01M
Shares Outstanding63.50M68.80M68.00M53.20M53.00M48.50M38.46M31.24M